Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325
Public ClinicalTrials.gov record NCT00807937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase II Study of 2 Oral Dose Groups of AZD7325, With a Lorazepam Arm, in Subjects With Generalized Anxiety Disorder (GAD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.
Study identification
- NCT ID
- NCT00807937
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 369 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2008 (Type not available)
- Primary completion
- May 2009 (Actual)
- Completion
- May 2009 (Actual)
- Last update posted
- Oct 8, 2010
2008 – 2009
United States locations
- U.S. sites
- 51
- U.S. states
- 22
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mesa | Arizona | — | — |
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | Carson | California | — | — |
| Research Site | Escondido | California | — | — |
| Research Site | Glendale | California | — | — |
| Research Site | Irvine | California | — | — |
| Research Site | Redlands | California | — | — |
| Research Site | Riverside | California | — | — |
| Research Site | Sherman Oaks | California | — | — |
| Research Site | Fort Lauderdale | Florida | — | — |
| Research Site | Fort Myers | Florida | — | — |
| Research Site | Gainsville | Florida | — | — |
| Research Site | Hallandale | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Maitland | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | St. Petersburg | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Hoffman Estates | Illinois | — | — |
| Research Site | Oak Brook | Illinois | — | — |
| Research Site | Schaumburg | Illinois | — | — |
| Research Site | Lafayette | Indiana | — | — |
| Research Site | Terre Haute | Indiana | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Glen Burnie | Maryland | — | — |
| Research Site | Westminster | Maryland | — | — |
| Research Site | Braintree | Massachusetts | — | — |
| Research Site | Piscataway | New Jersey | — | — |
| Research Site | Cedarhurst | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Staten Island | New York | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Willoughby | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Eugene | Oregon | — | — |
| Research Site | Salem | Oregon | — | — |
| Research Site | Allentown | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Bartlett | Tennessee | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Wichita Falls | Texas | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00807937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2010 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00807937 live on ClinicalTrials.gov.